|
Different gene mRNA expression on CD133+ cells compared to those on autologous CD133- cells * |
|||||||
| No. 66 |
No. 377 |
No. 1049 |
|||||
| Section |
Gene name |
CD133- |
CD133+ |
CD133- |
CD133+ |
CD133- |
CD133+ |
|
|
|||||||
| A |
CD90 |
1 |
15.6 ± 0.66 |
1 |
12.8 ± 0.94 |
1 |
13.5 ± 0.75 |
| CD44 |
1 |
5.7 ± 0.48 |
1 |
2.5 ± 0.22 |
1 |
2.8 ± 0.19 |
|
| CXCR4 |
1 |
337.8 ± 29.2 |
1 |
251.5 ± 22.1 |
1 |
264.9 ± 22.9 |
|
| Nestin |
1 |
21.4 ± 1.25 |
1 |
23.2 ± 1.65 |
1 |
22.1 ± 1.54 |
|
| MSI |
1 |
84 ± 7.6 |
1 |
75.4 ± 7.03 |
1 |
53.5 ± 6.2 |
|
| MELK |
1 |
1351 ± 95.8 |
1 |
467.7 ± 40.5 |
1 |
514.6 ± 45.6 |
|
| GLI-1 |
1 |
46 ± 3.8 |
1 |
43 ± 4.5 |
1 |
49 ± 5.9 |
|
| PTCH |
1 |
16 ± 1.48 |
1 |
13.5 ± 0.85 |
1 |
14.3 ± 1.24 |
|
|
|
|||||||
| B |
MGMT |
1 |
32.4 ± 2.5 |
1 |
34.7 ± 2.9 |
1 |
56.3 ± 4.2 |
| BCRP1 |
1 |
6.5 ± 0.43 |
1 |
4.3 ± 0.25 |
1 |
4.8 ± 0.24 |
|
| SIRT1 |
1 |
4.9 ± 0.34 |
1 |
4.2 ± 0.26 |
1 |
5.4 ± 0.29 |
|
| FLIP |
1 |
294 ± 25.5 |
1 |
157.6 ± 14.2 |
1 |
145.6 ± 13.7 |
|
| BCL-2 |
1 |
13.9 ± 0.95 |
1 |
4.9 ± 0.54 |
1 |
3.8 ± 0.54 |
|
| BCL-XL |
1 |
5.6 ± 0.39 |
1 |
3.2 ± 0.16 |
1 |
2.5 ± 0.14 |
|
| cIAP1 |
1 |
39.0 ± 3.5 |
1 |
4.3 ± 0.53 |
1 |
5.6 ± 0.65 |
|
| cIAP2 |
1 |
3 ± 0.25 |
1 |
1.9 ± 0.12 |
1 |
1.7 ± 0.14 |
|
| XIAP |
1 |
21.9 ± 2.2 |
1 |
9.7 ± 0.68 |
1 |
10.3 ± 0.91 |
|
| NAIP |
1 |
12.1 ± 0.75 |
1 |
6.4 ± 0.43 |
1 |
4.5 ± 0.62 |
|
| Survivin |
1 |
1.6 ± 0.08 |
1 |
2.3 ± 0.18 |
1 |
2.4 ± 0.18 |
|
| BAX |
1 |
0.33 ± 0.03 |
1 |
0.49 ± 0.06 |
1 |
0.21 ± 0.05 |
|
|
* Total RNA was extracted from both CD133+ and CD133- fraction after FACS sorting from three primary cultured cells (No. 66, 377 and 1049). Different gene mRNA expression was measured by real-time qPCR. The relative mRNA expression of different gene in CD133+ cells was presented as the fold increase compared to that of autologous CD133- cells (see Methods). Data was presented as Mean ± SD of three independent experiments. | |||||||
Liu et al. Molecular Cancer 2006 5:67 doi:10.1186/1476-4598-5-67 |
|||||||